Physician profile
Jason Barrett
NPI 1023549102
$8,349.48
in general payments reported to CMS, 2019-2025
15 companies · $3,295 in 2025
The $3,295 reported for 2025 was more than what 93% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $553 · 2023: $1,856 · 2024: $2,647 · 2025: $3,295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,685 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,685.37 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $2,251.32 | 2022-2025 | Invega Sustenna, Invega Trinza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,122.93 | 2023-2025 | Caplyta |
| Abbvie INC. | $856.52 | 2022-2025 | Vraylar |
| Alkermes, INC. | $804.21 | 2022-2025 | Aristada, Lybalvi, Aristada Initio |
| Neurocrine Biosciences, INC. | $768.28 | 2023-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $732.76 | 2022-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $640.87 | 2024-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| E.R. Squibb & Sons, L.L.C. | $629.72 | 2024-2025 | Cobenfy |
| Vanda Pharmaceuticals INC. | $210.42 | 2024-2025 | Fanapt |
| Ironshore Pharmaceuticals INC. | $138.37 | 2023 | Jornay Pm |
| Bioxcel Therapeutics, INC. | $78.48 | 2023 | Igalmi |
| Lundbeck LLC | $33.74 | 2025 | Abilify Maintena |
| Harmony Biosciences LLC | $30.62 | 2024 | |
| Indivior INC. | $28.22 | 2025 | Sublocade |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $23.02 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.